Parkinson’s disease research reveals gut bacteria and cellular protein blockage links

Researchers have identified new biological mechanisms that contribute to the progression of Parkinson’s disease, focusing on both the gut microbiome and cellular protein transport.

A team led by Professor Per Saris at the University of Helsinki found a link between the bacteria Desulfovibrio in the human gut and the disease. Using genetically modified worms, researchers observed that bacteria collected from the stool of Parkinson’s patients caused significantly larger and more frequent clumps of the protein alpha-synuclein. These protein clumps are a primary driver of the nerve cell damage characteristic of the disorder.

Complementary research from the Tofaris Lab at Oxford has clarified how alpha-synuclein damages brain cells at a molecular level. The study revealed that toxic forms of the protein latch onto Sec61A, a protein that acts as a gateway to the cell’s protein-processing center. This blockage prevents essential proteins from reaching lysosomes, the cell’s recycling centers, leading to a failure in waste clearance and further protein accumulation.

Findings suggest that reducing alpha-synuclein levels through CRISPR interference and stimulating the cell’s protein clearance machinery may offer potential pathways for future therapeutic interventions.